← All trials
NCT06654193
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2025
- Primary completion
- Jan 1, 2028
- Completion date
- Jan 1, 2028
- First posted
- Oct 23, 2024
- Last posted
- Oct 23, 2024
- Enrollment
- 70
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hope BiosciencesLead sponsor
- University of Texas at HoustonOfficial
- University of Texas at HoustonCollaborator
- University of Alabama, BirminghamCollaborator
- University of California, San FranciscoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.